Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial$dbrief report : clinical trials and observations
The multicenter, phase 3 German-Speaking Myeloma Multicenter Group (GMMG) ReLApsE trial randomized patients with relapsed and/or refractory multiple myeloma (RRMM) equally to lenalidomide/dexamethasone (LEN/DEX; 25 mg days 1-21, DEX 40 mg weekly, in 4-week cycles) reinduction, salvage high-dose chem...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
17 April 2025
|
| In: |
Blood
Year: 2025, Volume: 145, Issue: 16, Pages: 1780-1787 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood.2024027342 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood.2024027342
|
| Author Notes: | Marc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, Marc S. Raab, Sandra Sauer, Maximilian Merz, Elias Karl Mai, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Peter Brossart, Martin Goerner, Stefan Klein, Bertram Glass, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Ivana von Metzler, Hans W. Lindemann, Christof Scheid, Igor-Wolfgang Blau, Hans J. Salwender, Richard Noppeney, Britta Besemer, Katja C. Weisel, and Hartmut Goldschmidt, for the German-Speaking Myeloma Multicenter Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1927316596 | ||
| 003 | DE-627 | ||
| 005 | 20250913141607.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250603s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood.2024027342 |2 doi | |
| 035 | |a (DE-627)1927316596 | ||
| 035 | |a (DE-599)KXP1927316596 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bärtsch, Marc-Andrea |d 1988- |e VerfasserIn |0 (DE-588)1099464854 |0 (DE-627)858599074 |0 (DE-576)469306505 |4 aut | |
| 245 | 1 | 0 | |a Salvage autologous transplant in relapsed multiple myeloma |b long-term follow-up of the phase 3 GMMG ReLApsE trial$dbrief report : clinical trials and observations |c Marc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, Marc S. Raab, Sandra Sauer, Maximilian Merz, Elias Karl Mai, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Peter Brossart, Martin Goerner, Stefan Klein, Bertram Glass, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Ivana von Metzler, Hans W. Lindemann, Christof Scheid, Igor-Wolfgang Blau, Hans J. Salwender, Richard Noppeney, Britta Besemer, Katja C. Weisel, and Hartmut Goldschmidt, for the German-Speaking Myeloma Multicenter Group |
| 264 | 1 | |c 17 April 2025 | |
| 300 | |b Diagramme | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.06.2025 | ||
| 520 | |a The multicenter, phase 3 German-Speaking Myeloma Multicenter Group (GMMG) ReLApsE trial randomized patients with relapsed and/or refractory multiple myeloma (RRMM) equally to lenalidomide/dexamethasone (LEN/DEX; 25 mg days 1-21, DEX 40 mg weekly, in 4-week cycles) reinduction, salvage high-dose chemotherapy (sHDCT; melphalan 200 mg/m2), autologous stem cell transplantation (ASCT), and LEN maintenance (10 mg/d; transplant arm, n = 139) vs continuous LEN/DEX (control arm, n = 138). Ninety-four percent of patients had received frontline HDCT/ASCT. We report an updated analysis of survival end points with a median follow-up of 99 months. Median progression-free survival (PFS) was 20.5 and 19.3 months in the transplant and control arm, respectively (hazard ratio [HR], 0.98; P = .9). Median overall survival (OS) was 67.1 and 62.7 months, respectively, (HR 0.89; P = .44). Landmark analyses from sHDCT and the contemporaneous LEN/DEX cycle 5 were performed because of 29% dropout of patients before sHDCT/ASCT in the transplant arm but did not reveal significant differences in PFS/OS. Time to progression after frontline HDCT/ASCT was a prognostic factor but did not predict benefit from sHDCT/ASCT. The GMMG ReLApsE trial does not support use of sHDCT/ASCT in RRMM after frontline HDCT/ASCT. This trial was registered at www.clinicaltrialsregister.eu as #EudraCT2009-013856-61. | ||
| 700 | 1 | |a Schlenzka, Jana |d 1971- |e VerfasserIn |0 (DE-588)122728513 |0 (DE-627)70601782X |0 (DE-576)293397163 |4 aut | |
| 700 | 1 | |a Hielscher, Thomas |e VerfasserIn |0 (DE-588)1159594791 |0 (DE-627)1022977768 |0 (DE-576)50506068X |4 aut | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |e VerfasserIn |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 aut | |
| 700 | 1 | |a Sauer, Sandra |d 1975- |e VerfasserIn |0 (DE-588)1060031140 |0 (DE-627)799171778 |0 (DE-576)416132855 |4 aut | |
| 700 | 1 | |a Merz, Maximilian |d 1985- |e VerfasserIn |0 (DE-588)1023626950 |0 (DE-627)718419278 |0 (DE-576)367168251 |4 aut | |
| 700 | 1 | |a Mai, Elias K. |d 1985- |e VerfasserIn |0 (DE-588)1049182545 |0 (DE-627)781300274 |0 (DE-576)403130999 |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Luntz, Steffen P. |d 1968- |e VerfasserIn |0 (DE-588)120890216 |0 (DE-627)70506624X |0 (DE-576)292433077 |4 aut | |
| 700 | 1 | |a Jauch, Anna |d 1959- |e VerfasserIn |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 aut | |
| 700 | 1 | |a Brossart, Peter |e VerfasserIn |0 (DE-588)1171862997 |0 (DE-627)1040747183 |0 (DE-576)513889558 |4 aut | |
| 700 | 1 | |a Görner, Martin |d 1964- |e VerfasserIn |0 (DE-588)130475378 |0 (DE-627)707497817 |0 (DE-576)298218909 |4 aut | |
| 700 | 1 | |a Klein, Stefan |e VerfasserIn |0 (DE-588)1042491836 |0 (DE-627)769066372 |0 (DE-576)393988791 |4 aut | |
| 700 | 1 | |a Glaß, Bertram |d 1960- |e VerfasserIn |0 (DE-588)121205630 |0 (DE-627)705305538 |0 (DE-576)292585462 |4 aut | |
| 700 | 1 | |a Reimer, Peter |e VerfasserIn |0 (DE-588)1112143831 |0 (DE-627)866093141 |0 (DE-576)476388562 |4 aut | |
| 700 | 1 | |a Graeven, Ullrich |d 1960- |e VerfasserIn |0 (DE-588)111784298 |0 (DE-627)66756747X |0 (DE-576)349659087 |4 aut | |
| 700 | 1 | |a Fenk, Roland |d 1969- |e VerfasserIn |0 (DE-588)12196616X |0 (DE-627)081651813 |0 (DE-576)293022127 |4 aut | |
| 700 | 1 | |a Hänel, Mathias |d 1964- |e VerfasserIn |0 (DE-588)17362295X |0 (DE-627)698532414 |0 (DE-576)134465970 |4 aut | |
| 700 | 1 | |a Metzler, Ivana von |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lindemann, Hans W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Scheid, Christoph |e VerfasserIn |0 (DE-588)1075475244 |0 (DE-627)833299670 |0 (DE-576)443494495 |4 aut | |
| 700 | 1 | |a Blau, Igor-Wolfgang |d 1960- |e VerfasserIn |0 (DE-588)111826438 |0 (DE-627)566073560 |0 (DE-576)289713366 |4 aut | |
| 700 | 1 | |a Salwender, Hans |e VerfasserIn |0 (DE-588)1114928666 |0 (DE-627)869399993 |0 (DE-576)477578233 |4 aut | |
| 700 | 1 | |a Noppeney, Richard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Besemer, Britta |d 1982- |e VerfasserIn |0 (DE-588)143883828 |0 (DE-627)655894675 |0 (DE-576)33951518X |4 aut | |
| 700 | 1 | |a Weisel, Katja |d 1971- |e VerfasserIn |0 (DE-588)118014935 |0 (DE-627)079191975 |0 (DE-576)291668887 |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 145(2025), 16 vom: Apr., Seite 1780-1787 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Salvage autologous transplant in relapsed multiple myeloma long-term follow-up of the phase 3 GMMG ReLApsE trial$dbrief report : clinical trials and observations |
| 773 | 1 | 8 | |g volume:145 |g year:2025 |g number:16 |g month:04 |g pages:1780-1787 |g extent:8 |a Salvage autologous transplant in relapsed multiple myeloma long-term follow-up of the phase 3 GMMG ReLApsE trial$dbrief report : clinical trials and observations |
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood.2024027342 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250603 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 27 |y j | ||
| 998 | |g 1042491836 |a Klein, Stefan |m 1042491836:Klein, Stefan |d 60000 |e 60000PK1042491836 |k 0/60000/ |p 13 | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 911500 |d 50000 |e 910000PJ1025525140 |e 911500PJ1025525140 |e 50000PJ1025525140 |k 0/910000/ |k 1/910000/911500/ |k 0/50000/ |p 10 | ||
| 998 | |g 120890216 |a Luntz, Steffen P. |m 120890216:Luntz, Steffen P. |d 910000 |d 913000 |e 910000PL120890216 |e 913000PL120890216 |k 0/910000/ |k 1/910000/913000/ |p 9 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ | ||
| 998 | |g 1049182545 |a Mai, Elias K. |m 1049182545:Mai, Elias K. |d 910000 |d 910100 |d 50000 |e 910000PM1049182545 |e 910100PM1049182545 |e 50000PM1049182545 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 7 | ||
| 998 | |g 1023626950 |a Merz, Maximilian |m 1023626950:Merz, Maximilian |d 50000 |e 50000PM1023626950 |k 0/50000/ |p 6 | ||
| 998 | |g 1060031140 |a Sauer, Sandra |m 1060031140:Sauer, Sandra |d 910000 |d 910100 |e 910000PS1060031140 |e 910100PS1060031140 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1159594791 |a Hielscher, Thomas |m 1159594791:Hielscher, Thomas |d 50000 |e 50000PH1159594791 |k 0/50000/ |p 3 | ||
| 998 | |g 122728513 |a Schlenzka, Jana |m 122728513:Schlenzka, Jana |d 910000 |d 910100 |e 910000PS122728513 |e 910100PS122728513 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1099464854 |a Bärtsch, Marc-Andrea |m 1099464854:Bärtsch, Marc-Andrea |d 910000 |d 910100 |e 910000PB1099464854 |e 910100PB1099464854 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1927316596 |e 4730205677 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Blood","title":"Blood","subtitle":"journal of the American Society of Hematology"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["1468538-3"],"eki":["266886647"],"issn":["1528-0020"]},"corporate":[{"role":"isb","display":"American Society of Hematology"}],"disp":"Salvage autologous transplant in relapsed multiple myeloma long-term follow-up of the phase 3 GMMG ReLApsE trial$dbrief report : clinical trials and observationsBlood","titleAlt":[{"title":"Blood online"}],"part":{"year":"2025","text":"145(2025), 16 vom: Apr., Seite 1780-1787","volume":"145","extent":"8","issue":"16","pages":"1780-1787"},"pubHistory":["1.1946 -"],"origin":[{"publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"recId":"266886647","language":["eng"],"note":["Gesehen am 21.04.2023"]}],"physDesc":[{"noteIll":"Diagramme","extent":"8 S."}],"title":[{"subtitle":"long-term follow-up of the phase 3 GMMG ReLApsE trial$dbrief report : clinical trials and observations","title_sort":"Salvage autologous transplant in relapsed multiple myeloma","title":"Salvage autologous transplant in relapsed multiple myeloma"}],"id":{"doi":["10.1182/blood.2024027342"],"eki":["1927316596"]},"person":[{"role":"aut","given":"Marc-Andrea","family":"Bärtsch","display":"Bärtsch, Marc-Andrea"},{"family":"Schlenzka","display":"Schlenzka, Jana","role":"aut","given":"Jana"},{"display":"Hielscher, Thomas","family":"Hielscher","given":"Thomas","role":"aut"},{"display":"Raab, Marc-Steffen","family":"Raab","given":"Marc-Steffen","role":"aut"},{"role":"aut","given":"Sandra","family":"Sauer","display":"Sauer, Sandra"},{"role":"aut","given":"Maximilian","family":"Merz","display":"Merz, Maximilian"},{"family":"Mai","display":"Mai, Elias K.","role":"aut","given":"Elias K."},{"role":"aut","given":"Carsten","family":"Müller-Tidow","display":"Müller-Tidow, Carsten"},{"role":"aut","given":"Steffen P.","family":"Luntz","display":"Luntz, Steffen P."},{"family":"Jauch","display":"Jauch, Anna","role":"aut","given":"Anna"},{"display":"Brossart, Peter","family":"Brossart","given":"Peter","role":"aut"},{"given":"Martin","role":"aut","display":"Görner, Martin","family":"Görner"},{"display":"Klein, Stefan","family":"Klein","given":"Stefan","role":"aut"},{"given":"Bertram","role":"aut","display":"Glaß, Bertram","family":"Glaß"},{"family":"Reimer","display":"Reimer, Peter","role":"aut","given":"Peter"},{"family":"Graeven","display":"Graeven, Ullrich","role":"aut","given":"Ullrich"},{"family":"Fenk","display":"Fenk, Roland","role":"aut","given":"Roland"},{"display":"Hänel, Mathias","family":"Hänel","given":"Mathias","role":"aut"},{"family":"Metzler","display":"Metzler, Ivana von","role":"aut","given":"Ivana von"},{"role":"aut","given":"Hans W.","family":"Lindemann","display":"Lindemann, Hans W."},{"given":"Christoph","role":"aut","display":"Scheid, Christoph","family":"Scheid"},{"role":"aut","given":"Igor-Wolfgang","family":"Blau","display":"Blau, Igor-Wolfgang"},{"given":"Hans","role":"aut","display":"Salwender, Hans","family":"Salwender"},{"role":"aut","given":"Richard","family":"Noppeney","display":"Noppeney, Richard"},{"display":"Besemer, Britta","family":"Besemer","given":"Britta","role":"aut"},{"role":"aut","given":"Katja","family":"Weisel","display":"Weisel, Katja"},{"display":"Goldschmidt, Hartmut","family":"Goldschmidt","given":"Hartmut","role":"aut"}],"name":{"displayForm":["Marc-Andrea Baertsch, Jana Schlenzka, Thomas Hielscher, Marc S. Raab, Sandra Sauer, Maximilian Merz, Elias Karl Mai, Carsten Müller-Tidow, Steffen Luntz, Anna Jauch, Peter Brossart, Martin Goerner, Stefan Klein, Bertram Glass, Peter Reimer, Ullrich Graeven, Roland Fenk, Mathias Haenel, Ivana von Metzler, Hans W. Lindemann, Christof Scheid, Igor-Wolfgang Blau, Hans J. Salwender, Richard Noppeney, Britta Besemer, Katja C. Weisel, and Hartmut Goldschmidt, for the German-Speaking Myeloma Multicenter Group"]},"origin":[{"dateIssuedDisp":"17 April 2025","dateIssuedKey":"2025"}],"recId":"1927316596","language":["eng"],"note":["Gesehen am 03.06.2025"]} | ||
| SRT | |a BAERTSCHMASALVAGEAUT1720 | ||